Profile: Mekong Capital’s Chad Ovel
New funds aim to close the early-stage gap in SE Asian impact investing
LiveSpo represents Vietnam, announces world’s first spore probiotics in nasal spray form at the BIO International Convention
Vietnam’s Mekong Capital plans Southeast Asia climate fund as early as 2024
Vietnam’s Mekong Capital in no rush to score exits from MEF III, targets one this year
Why this Vietnam-based PE firm doesn’t bet on startups
Investing in Vietnam: “Their perception of risk is wrong”
Ellen Van: What is Regenerative Farming?
A promising picture for multi-cancer early detection in Southeast Asia – latest update from biotech firm Gene Solutions
Marou plans to expand in Vietnam
How long does Mekong Capital Partner with an investee company?
The time’s ripe to invest in Vietnamese private enterprises
English
English
